Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.

OBJECTIVE:To evaluate intraperitoneal (IP) tumor engraftment, metastasis and growth in a pre-clinical murine epithelial ovarian cancer (EOC) model using both transabdominal ultrasound (TAUS) and bioluminescence in vivo imaging system (IVIS). METHODS:Ten female C57Bl/6J mice at six weeks of age were...

Full description

Bibliographic Details
Main Authors: Laura M Chambers, Emily Esakov, Chad Braley, Mariam AlHilli, Chad Michener, Ofer Reizes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0228511
_version_ 1818404438671360000
author Laura M Chambers
Emily Esakov
Chad Braley
Mariam AlHilli
Chad Michener
Ofer Reizes
author_facet Laura M Chambers
Emily Esakov
Chad Braley
Mariam AlHilli
Chad Michener
Ofer Reizes
author_sort Laura M Chambers
collection DOAJ
description OBJECTIVE:To evaluate intraperitoneal (IP) tumor engraftment, metastasis and growth in a pre-clinical murine epithelial ovarian cancer (EOC) model using both transabdominal ultrasound (TAUS) and bioluminescence in vivo imaging system (IVIS). METHODS:Ten female C57Bl/6J mice at six weeks of age were included in this study. Five mice underwent IP injection of 5x106 ID8-luc cells (+ D- luciferin) and the remaining five mice underwent IP injection of ID8-VEGF cells. Monitoring of tumor growth and ascites was performed weekly starting at seven days post-injection until study endpoint. ID8-luc mice were monitored using both TAUS and IVIS, and ID8-VEGF mice underwent TAUS monitoring only. Individual tumor implant dimension and total tumor volume were calculated. Average luminescent intensity was calculated and reported per mouse abdomen. Tumor detection was confirmed by gross evaluation and histopathology. All data are presented as mean +/- standard deviation. RESULTS:Overall, tumors were successfully detected in all ten mice using TAUS and IVIS, and tumor detection correlated with terminal endpoint histology/ H&E staining. For TAUS, the smallest confirmed tumor measurements were at seven days post-injection with mean long axis of 2.23mm and mean tumor volume of 4.17mm3. However, IVIS imaging was able to detect tumor growth at 14 days post-injection. Ascites formation was detected in mice at 21 days post-injection. CONCLUSIONS:TAUS is highly discriminatory for monitoring EOC in pre-clinical murine model, allowing for detection of tumor dimension as small as 2 mm and as early as seven days post-injection compared to IVIS. In addition, TAUS provides relevant information for ascites development and detection of multiple small metastatic tumor implants. TAUS provides an accurate and reliable method to detect and monitor IP EOC growth in mouse xenografts.
first_indexed 2024-12-14T08:40:09Z
format Article
id doaj.art-98d7067390a44d5d8680dfe2a8c3e696
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T08:40:09Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-98d7067390a44d5d8680dfe2a8c3e6962022-12-21T23:09:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01154e022851110.1371/journal.pone.0228511Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.Laura M ChambersEmily EsakovChad BraleyMariam AlHilliChad MichenerOfer ReizesOBJECTIVE:To evaluate intraperitoneal (IP) tumor engraftment, metastasis and growth in a pre-clinical murine epithelial ovarian cancer (EOC) model using both transabdominal ultrasound (TAUS) and bioluminescence in vivo imaging system (IVIS). METHODS:Ten female C57Bl/6J mice at six weeks of age were included in this study. Five mice underwent IP injection of 5x106 ID8-luc cells (+ D- luciferin) and the remaining five mice underwent IP injection of ID8-VEGF cells. Monitoring of tumor growth and ascites was performed weekly starting at seven days post-injection until study endpoint. ID8-luc mice were monitored using both TAUS and IVIS, and ID8-VEGF mice underwent TAUS monitoring only. Individual tumor implant dimension and total tumor volume were calculated. Average luminescent intensity was calculated and reported per mouse abdomen. Tumor detection was confirmed by gross evaluation and histopathology. All data are presented as mean +/- standard deviation. RESULTS:Overall, tumors were successfully detected in all ten mice using TAUS and IVIS, and tumor detection correlated with terminal endpoint histology/ H&E staining. For TAUS, the smallest confirmed tumor measurements were at seven days post-injection with mean long axis of 2.23mm and mean tumor volume of 4.17mm3. However, IVIS imaging was able to detect tumor growth at 14 days post-injection. Ascites formation was detected in mice at 21 days post-injection. CONCLUSIONS:TAUS is highly discriminatory for monitoring EOC in pre-clinical murine model, allowing for detection of tumor dimension as small as 2 mm and as early as seven days post-injection compared to IVIS. In addition, TAUS provides relevant information for ascites development and detection of multiple small metastatic tumor implants. TAUS provides an accurate and reliable method to detect and monitor IP EOC growth in mouse xenografts.https://doi.org/10.1371/journal.pone.0228511
spellingShingle Laura M Chambers
Emily Esakov
Chad Braley
Mariam AlHilli
Chad Michener
Ofer Reizes
Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
PLoS ONE
title Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
title_full Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
title_fullStr Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
title_full_unstemmed Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
title_short Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
title_sort use of transabdominal ultrasound for the detection of intra peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer
url https://doi.org/10.1371/journal.pone.0228511
work_keys_str_mv AT lauramchambers useoftransabdominalultrasoundforthedetectionofintraperitonealtumorengraftmentandgrowthinmousexenograftsofepithelialovariancancer
AT emilyesakov useoftransabdominalultrasoundforthedetectionofintraperitonealtumorengraftmentandgrowthinmousexenograftsofepithelialovariancancer
AT chadbraley useoftransabdominalultrasoundforthedetectionofintraperitonealtumorengraftmentandgrowthinmousexenograftsofepithelialovariancancer
AT mariamalhilli useoftransabdominalultrasoundforthedetectionofintraperitonealtumorengraftmentandgrowthinmousexenograftsofepithelialovariancancer
AT chadmichener useoftransabdominalultrasoundforthedetectionofintraperitonealtumorengraftmentandgrowthinmousexenograftsofepithelialovariancancer
AT oferreizes useoftransabdominalultrasoundforthedetectionofintraperitonealtumorengraftmentandgrowthinmousexenograftsofepithelialovariancancer